https://www.fiercebiotech.com/biotech/ocean-biomedical-signs-32m-pact-polish-biotech-ykl-40-inhibitors
Ocean Biomedical pens $32M pact for Polish YKL-40 inhibitors
Oct 15, 2024 - Ocean Biomedical hopes the preclinical YKL-40 inhibitors have potential against cancers, inflammatory and fibrotic diseases.
ocean biomedicalykl 40pens32mpact
https://www.epo.org/en/boards-of-appeal/decisions/t131389eu1
T 1389/13 (YKL-40 monoclonal antibodies/BIO-Y) of 10.07.2018